AREV Nanotec Announces Corporate Update via Zoom on March 12, 2021


VANCOUVER, BC – TheNewswire - February 25, 2021 - AREV NANOTEC BRANDS INC. (CSE:AREV) (OTC:AREVF) (CNSX:AREV.CN) (“AREV Nanotec” or “AREV”) announces that the Company will hold a video conference on Friday, March 12, 2021 at 1 pm PST (4 pm EST), to update on recent corporate initiatives in the life science industry, including a review of its new relationships within the biotechnology industry and establishment of its Scientific Advisory Board (SAB) and related appointments, all in support of the Company’s value-based strategic pivot.


Mike Withrow, CEO of AREV Nanotec, said, “AREV Nanotec looks forward to providing a corporate update with insight into its strategic positioning of the Company, entering biotech development utilizing its state-of-the-art extraction technologies.  The Company is in the development of its Ready-to-Use Therapeutic Food (RUTF) to counter malnutrition, branded as SUS-TAINN, its evidenced-based enteral formulas for unmet needs, and its phytomedicinal platform.  We will also introduce our growing team of biotechnology and scientific experts to the investment community and beyond.”


Anticipated speakers include AREV Senior Scientific Advisor Roscoe M. Moore, Jr., DVM, MPH, PHD, Former Asst U.S. Surgeon General (retired); Scientific Advisor Jay Stratton Noller, PHD; Board Member Kevin J. Phelps; CEO and Board Chair Michael Withrow, among others, moderated by Chad S. Johnson, Esq.

Join Zoom Meeting


Meeting ID: 997 779 8307

One tap mobile

+16473744685,,9977798307# Canada


Find your local number:


For further information, contact Mike Withrow, 778-929-6536. For more information visit

On behalf of the Board,

Mike Withrow
CEO & Director

About AREV NanoTec Brands Inc.  
AREV NanoTec Brands Inc. (CSE: AREV) (OTC: AREVF) produces phytomedicinal extracts via its proprietary state-of-the-art extraction methodologies for the life science industry. These premium ingredients are utilized in SUS-TAINN™, a

Ready-To-Use Therapeutic Food (RUTF) to impact global malnutrition on Severe / Acute Malnutrition (SAM) and the Enteral Formula markets. The AREV model is to advance extraction technologies that provide opportunities for next generation phytomedicine.  AREV Nanotec is a member of BIO, the world’s largest trade association representing biotechnology companies, academic institutions, state biotechnology centers, and related organizations across the United States and in more than 30 other countries.



Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, and continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws. This press release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements.  Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks various risk factors discussed in the Company’s Management’s Discussion and Analysis under the Company’s profile on   

Copyright (c) 2021 TheNewswire - All rights reserved.

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.